More than 1 billion people worldwide live with a mental health condition, yet depression and anxiety alone drain an estimated USD 1 trillion from the global economy every year (World Health Organization, 2025). Digital tools are racing to fill that gap. The global mental health apps market was valued at USD 7.48 billion in 2024 and is projected to reach USD 17.52 billion by 2030 (Grand View Research, 2025), while US digital health funding hit USD 14.2 billion in 2025 (Rock Health, 2025). The first rigorous clinical trial of a generative-AI therapy chatbot reported a 51% average reduction in depression symptoms over four weeks (Dartmouth / NEJM AI, 2025), even as median 30-day retention across mental health apps sits near 3.3% (Journal of Medical Internet Research, 2019). This analysis consolidates data from the World Health Organization, the American Psychological Association, Rock Health, World Psychiatry, and 15 other primary sources to separate the demand, the money, and the clinical evidence.
TL;DR
- The global mental health apps market was USD 7.48 billion in 2024, projected to USD 17.52 billion by 2030 at a 14.59% CAGR (Grand View Research, 2025).
- More than 1 billion people live with a mental health condition, and fewer than 10% receive care in low-income countries (WHO, 2025).
- Over 320 million people used health and wellness apps in 2024 (Business of Apps, 2026).
- Calm earned about USD 210 million in 2025 (down 24% year over year); Headspace earned around USD 140 million (Business of Apps, 2026).
- A 176-trial meta-analysis found apps cut depression symptoms with a small effect (g=0.28) and a number-needed-to-treat of 11.5 (World Psychiatry, 2024).
- Median 15-day retention was 3.9% and 30-day retention 3.3% across 93 apps (Journal of Medical Internet Research, 2019).
- Dartmouth’s Therabot trial reported a 51% average drop in depression symptoms over four weeks (NEJM AI, 2025).
- 77% of psychologists have discussed a patient’s AI use, and 13% observed patients forming relationship-like bonds with chatbots (APA, 2026).
- 59% of reviewed mental health apps earned a Privacy Not Included warning (Mozilla Foundation, 2023).
- US digital health funding hit USD 14.2 billion in 2025, up 35%, with AI mental health a flashpoint (Rock Health, 2025).
- In 2024, 19.3% of US adults took medication and 14.0% received therapy for mental health (CDC/NCHS, 2024).
- Of 162 anxiety and depression apps claiming an evidence-based framework, only 6.2% had published efficacy evidence (JMIR, 2020).
1. Market Size, Growth, and Investment
The category is expanding, but the headline numbers hide a split. US digital health funding rebounded to USD 14.2 billion in 2025, a 35% jump over 2024 and the highest total since 2022 (Rock Health, 2025) - yet consumer subscription revenue for the biggest apps softened in the same period. Capital is flowing to fewer, larger rounds and to clinical or payer-facing companies rather than direct-to-consumer meditation. Market-sizing firms disagree sharply on the category’s value because some count only self-help apps while others fold in teletherapy. For the broader shift toward clinical software, see our AI in healthcare statistics roundup.
| Metric | Value | Source |
|---|---|---|
| Global mental health apps market, 2024 | USD 7.48 billion | Grand View Research, 2025 |
| Projected market, 2030 | USD 17.52 billion (14.59% CAGR) | Grand View Research, 2025 |
| Alternative 2025 market estimate | USD 9.61 billion | SNS Insider, 2025 |
| Depression and anxiety management segment, 2024 | USD 2,151.5M (28.7% share) | Grand View Research, 2025 |
| North America market share, 2024 | 36.43% | Grand View Research, 2025 |
| iOS revenue share, 2025 | ~52.3% | SNS Insider, 2025 |
| US digital health funding, 2025 | USD 14.2 billion (+35% YoY) | Rock Health, 2025 |
| Digital health M&A deals, 2025 | 195 (+61% YoY) | Rock Health, 2025 |
Outlier note: published 2024-2025 market estimates span roughly USD 7.48 billion to USD 9.94 billion. The spread reflects category definitions, not measurement error - some firms include telepsychiatry and teletherapy platforms that others exclude.
2. Users, Downloads, and the Biggest Apps
Scale and profitability are diverging. Calm’s estimated revenue fell about 24% to USD 210 million in 2025 (Business of Apps, 2026), and Headspace shed 300,000 paid subscribers in the same year - a sign that direct-to-consumer subscription fatigue has reached even the category leaders. Growth is migrating to enterprise seats and insurer partnerships. In therapy specifically, BetterHelp and Talkspace increasingly sell through employers and payers rather than individual subscriptions, a pattern detailed in our telehealth statistics roundup.
| Metric | Value | Source |
|---|---|---|
| Health and wellness app users, 2024 | 320 million+ | Business of Apps, 2026 |
| Wellness app revenue, 2025 | USD 848M (-6.2% YoY) | Business of Apps, 2026 |
| Calm revenue, 2025 | ~USD 210M (-24% YoY) | Business of Apps, 2026 |
| Calm paying subscribers | ~4.5 million | Sacra, 2025 |
| Headspace paid subscribers, 2025 | 2 million (-300k) | Business of Apps, 2026 |
| BetterHelp users | 5 million+ (>USD 1B revenue) | Teladoc Health, 2025 |
| Meditation download share (Calm, Headspace, Insight Timer) | 87% | Sensor Tower, 2024 |
Context note: roughly 80% of people who begin BetterHelp registration never become active users (Behavioral Health Business, 2025) - a reminder that download and sign-up counts overstate real use.
3. AI Chatbots and the Therapy Question
The clinical case for conversational AI is advancing faster than the consensus on its safety. Patients diagnosed with depression saw a 51% average reduction in symptoms after four weeks with the Therabot chatbot (Dartmouth / NEJM AI, 2025) - the first randomized trial of a purpose-built generative therapy bot. Meta-analytic data also suggest chatbot-driven apps outperform static ones. Yet the American Psychological Association has warned that generative AI should not stand in for a clinician, and its survey of psychologists shows patients already bringing AI into the therapy room, sometimes forming attachments to it. That attachment pattern is quantified in our AI companion apps statistics and broader AI chatbot statistics roundups.
| Metric | Value | Source |
|---|---|---|
| Therabot RCT depression symptom reduction | 51% (4 weeks) | Dartmouth / NEJM AI, 2025 |
| Therabot RCT sample | 210 adults (106 vs 104 control) | NEJM AI, 2025 |
| Chatbot-based app effect on depression (meta) | g=0.53 vs 0.28 non-chatbot | World Psychiatry, 2024 |
| AI chatbot vs nurse hotline (pilot RCT) | Comparable anxiety and depression relief | JMIR Human Factors, 2025 |
| Psychologists who discussed a patient’s AI use | 77% | APA, 2026 |
| Patients forming a relationship-like bond with a chatbot | 13% | APA, 2026 |
| Patients using AI to self-diagnose | 39% | APA, 2026 |
Note: the APA issued a 2025 health advisory stating that generative AI should not be used for psychotherapy, psychological treatment, diagnosis, or crisis support (APA, 2025).
4. Does It Work? Clinical Evidence and the Engagement Gap
Efficacy is real but modest, and it collapses outside the lab. A meta-analysis of 176 randomized trials found apps produce only a small effect on depression (g=0.28), with a number-needed-to-treat of 11.5 (World Psychiatry, 2024) - meaningful at population scale, but far below what trial headlines imply. The bigger problem is that most people stop. Naturalistic usage data show single-digit retention within weeks, and the field cannot even measure engagement consistently, undercutting cross-study comparison.
| Metric | Value | Source |
|---|---|---|
| RCTs in largest efficacy meta-analysis | 176 (33,567 participants) | World Psychiatry, 2024 |
| Effect on depression / anxiety | g=0.28 / g=0.26 | World Psychiatry, 2024 |
| Weighted dropout across trials | 23.6% | World Psychiatry, 2024 |
| Median 15-day / 30-day retention | 3.9% / 3.3% | JMIR (Baumel et al.), 2019 |
| Median daily open rate | 4.0% | JMIR (Baumel et al.), 2019 |
| Apps claiming an evidence-based framework with published efficacy | 6.2% (10 of 162) | JMIR, 2020 |
| Trials not reporting engagement data | 24% | npj Digital Medicine, 2025 |
Note: retention varies sharply by app type - peer-support apps held about 8.9% of users at day 30 versus near-zero for breathing-exercise apps (JMIR, 2019). The 2019 retention benchmark and 2020 evidence-base audit remain the most comprehensive naturalistic and app-store analyses of their kind; flagged as most recent available.
5. Privacy, Safety, and Trust
For a category handling some of the most sensitive personal data, safeguards are inconsistent. Mozilla flagged 59% of the top mental health apps it reviewed with a Privacy Not Included warning (Mozilla Foundation, 2023), and two in five had gotten worse year over year. Clinicians share the skepticism: nearly all surveyed psychologists doubt that technology companies will protect mental health data. Regulatory action has followed disclosure failures, most visibly against BetterHelp.
| Metric | Value | Source |
|---|---|---|
| Mental health apps with a Privacy Not Included warning | 59% | Mozilla Foundation, 2023 |
| Apps that got worse on privacy year over year | 40% | Mozilla Foundation, 2023 |
| US FTC penalty against BetterHelp for sharing health data for ads | USD 7.8 million | US FTC, 2023 |
| Apps earning a “Best Of” privacy citation | 2 (PTSD Coach, Wysa) | Mozilla Foundation, 2023 |
| Psychologists distrusting tech firms with mental health data | 94% | APA, 2026 |
| Psychologists concerned chatbots reinforce negative behavior or delusions | 97% | APA, 2026 |
Note: this review remains the most recent dedicated privacy audit of the mental health app category; flagged as most recent available. The FTC action against BetterHelp stemmed from sharing consumers’ health data with advertising platforms after promising not to.
6. The Need: Burden, Spending, and the Treatment Gap
The demand context explains why apps scaled so quickly. Depression and anxiety cost the global economy an estimated USD 1 trillion a year, yet governments devote a median of just 2% of health budgets to mental health (WHO, 2025) - a funding gap that leaves most people untreated and pushes many toward self-help software. In the United States, formal treatment is rising but still reaches a minority of adults, leaving room for lower-cost digital options to grow alongside, not instead of, clinical care.
| Metric | Value | Source |
|---|---|---|
| People living with a mental health condition | 1 billion+ | WHO, 2025 |
| Annual global economic cost (depression and anxiety) | ~USD 1 trillion | WHO, 2025 |
| Government mental health budget share (global median) | 2% | WHO, 2025 |
| Lives lost to suicide, 2021 | 727,000 | WHO, 2025 |
| US adults taking medication for mental health, 2024 | 19.3% | CDC/NCHS, 2024 |
| US adults receiving therapy for mental health, 2024 | 14.0% | CDC/NCHS, 2024 |
Note: in low-income countries fewer than 10% of people with a mental health condition receive care, versus more than 50% in higher-income nations (WHO, 2025). Among US adults in 2024, women were far more likely than men to take medication (24.9% vs 13.4%) or receive therapy (16.9% vs 10.9%) (CDC/NCHS, 2024).
Summary: Mental Health Apps by the Numbers
| Metric | Value | Source |
|---|---|---|
| Global mental health apps market, 2024 to 2030 | USD 7.48B to USD 17.52B | Grand View Research, 2025 |
| BetterHelp sign-ups that never become active users | ~80% | Behavioral Health Business, 2025 |
| US digital health funding, 2025 | USD 14.2 billion (+35%) | Rock Health, 2025 |
| Digital health M&A deals, 2025 | 195 (+61%) | Rock Health, 2025 |
| Meditation download share (Calm, Headspace, Insight Timer) | 87% | Sensor Tower, 2024 |
| Calm revenue, 2025 | ~USD 210M (-24%) | Business of Apps, 2026 |
| Alternative 2025 market estimate | USD 9.61 billion | SNS Insider, 2025 |
| BetterHelp users | 5 million+ | Teladoc Health, 2025 |
| Therabot depression symptom reduction | 51% (4 weeks) | Dartmouth / NEJM AI, 2025 |
| Depression app effect (176 RCTs) | g=0.28, NNT 11.5 | World Psychiatry, 2024 |
| Trials not reporting engagement data | 24% | npj Digital Medicine, 2025 |
| Median 30-day retention | 3.3% | JMIR (Baumel et al.), 2019 |
| Apps with published efficacy evidence | 6.2% | JMIR, 2020 |
| Psychologists discussing patient AI use | 77% | APA, 2026 |
| Apps with a Privacy Not Included warning | 59% | Mozilla Foundation, 2023 |
| FTC penalty against BetterHelp | USD 7.8 million | US FTC, 2023 |
| People living with a mental health condition | 1 billion+ | WHO, 2025 |
| US adults on medication for mental health, 2024 | 19.3% | CDC/NCHS, 2024 |
Methodology and Sources
Data was gathered by aggregating figures from primary reports, peer-reviewed studies, company and regulatory disclosures, and named industry trackers published mainly in 2024-2026, cross-referencing market and user figures across multiple sources and flagging older benchmarks where no newer equivalent exists.
Sources cited:
- World Health Organization - Over a billion people living with mental health conditions, news release and mental health atlas data, 2025
- Grand View Research - Mental Health Apps Market Report, 2025
- SNS Insider - Mental Health Apps Market Report, 2025
- Rock Health - 2025 Year-End Digital Health Funding Overview, 2025
- Business of Apps - Wellness App Revenue and Usage Statistics, 2026; Calm and Headspace data pages, 2026
- Sensor Tower - State of Mobile Health and Fitness, 2025
- Behavioral Health Business - BetterHelp and Talkspace earnings coverage, 2025
- Teladoc Health - BetterHelp segment disclosures, 2025
- American Psychological Association - Chatbots and Mental Health survey report, 2026; AI and wellness apps advisory, 2025
- Dartmouth College / NEJM AI - Therabot randomized trial, 2025
- JMIR Human Factors - AI chatbot vs nurse hotline pilot RCT, 2025
- World Psychiatry (Linardon et al.) - Meta-analysis of 176 RCTs, 2024
- Journal of Medical Internet Research (Baumel et al.) - Objective User Engagement With Mental Health Apps, 2019; Apps With Maps evidence-based framework analysis, 2020
- npj Digital Medicine - Persuasive design and engagement meta-analysis, 2025
- Mozilla Foundation - Privacy Not Included: Mental Health Apps, 2023
- US Federal Trade Commission - BetterHelp enforcement action, 2023
- CDC / National Center for Health Statistics - Mental Health Treatment Among Adults, 2024
Data watch: Rock Health publishes its digital health funding overview annually, with the H1 2026 update expected mid-2026 and a full-year 2026 report in late 2026 or early 2027. Business of Apps refreshes its wellness and per-app statistics through the year. The APA is likely to update its Chatbots and Mental Health survey annually given the pace of AI adoption. Grand View Research, SNS Insider, and Sensor Tower issue new market and mobile reports each year, and the CDC/NCHS mental health treatment brief typically updates with the next survey cycle.
Last updated: July 10, 2026.
We review and update this page quarterly as new data is published.